Cargando…

Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice

The understanding of the molecular mechanisms of the immune tolerance induced by the tumoral microenvironment is fundamental to prevent cancer development or to treat cancer patients using immunotherapy. Actually, there are investigations about “addressed‐drugs” against cancer cells without affectin...

Descripción completa

Detalles Bibliográficos
Autores principales: Roldan‐Deamicis, Agustina, Alonso, Eliana, Brie, Belén, Braico, Diego Aguilera, Balogh, Gabriela Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055164/
https://www.ncbi.nlm.nih.gov/pubmed/27401257
http://dx.doi.org/10.1002/cam4.744
_version_ 1782458727397326848
author Roldan‐Deamicis, Agustina
Alonso, Eliana
Brie, Belén
Braico, Diego Aguilera
Balogh, Gabriela Andrea
author_facet Roldan‐Deamicis, Agustina
Alonso, Eliana
Brie, Belén
Braico, Diego Aguilera
Balogh, Gabriela Andrea
author_sort Roldan‐Deamicis, Agustina
collection PubMed
description The understanding of the molecular mechanisms of the immune tolerance induced by the tumoral microenvironment is fundamental to prevent cancer development or to treat cancer patients using immunotherapy. Actually, there are investigations about “addressed‐drugs” against cancer cells without affecting normal cells. It could be ideal to find selective and specific compounds that only recognize and destroy tumor cells without damaging the host normal cells. For thousands of years, mushrooms have been used for medicinal purposes because of their curative properties. D‐Fraction, an extract of Maitake (from the edible Grifola frondosa mushroom), rich in β‐glucans, exert notable effects in the immune system. Until now, some published articles suggest that Maitake D‐Fraction could have anti‐tumoral activity, prevent oncogenesis and metastasis in some tumor types. However, there are no clear data about Maitake D‐Fraction action on breast cancer prevention and its exact molecular mechanisms are not yet elucidated. The experiments were performed employing 25 female BALBc mice that were treated with and without Maitake D‐Fraction Pro4X or Maitake Standard for 15 days by daily intraperitoneal injection. After treatment period, all mice were implanted with murine tumor cells LM3 to induce mammary tumorigenesis. Animals were checked weekly and killed after 46 days of LM3 transplant; percentage of cancer prevention, rate of tumor growing, and overall survival were determined. Under dissection, the internal organs were evaluated histologically and genetically by RT‐PCR. We found that 5 mg/kg per day of Maitake D‐Fraction Pro4X, administered dairy during 15 days to BALBc mice was able to block more than 60% breast cancer development. However, Maitake Standard prevents oncogenesis in 26% to respect control. In this work, we found that Maitake D‐Fraction Pro4X, administered to BALBc mice, prevents breast carcinogenesis, block tumor invasiveness, reduce angiogenesis, and increase overall survival.
format Online
Article
Text
id pubmed-5055164
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50551642016-12-12 Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice Roldan‐Deamicis, Agustina Alonso, Eliana Brie, Belén Braico, Diego Aguilera Balogh, Gabriela Andrea Cancer Med Cancer Biology The understanding of the molecular mechanisms of the immune tolerance induced by the tumoral microenvironment is fundamental to prevent cancer development or to treat cancer patients using immunotherapy. Actually, there are investigations about “addressed‐drugs” against cancer cells without affecting normal cells. It could be ideal to find selective and specific compounds that only recognize and destroy tumor cells without damaging the host normal cells. For thousands of years, mushrooms have been used for medicinal purposes because of their curative properties. D‐Fraction, an extract of Maitake (from the edible Grifola frondosa mushroom), rich in β‐glucans, exert notable effects in the immune system. Until now, some published articles suggest that Maitake D‐Fraction could have anti‐tumoral activity, prevent oncogenesis and metastasis in some tumor types. However, there are no clear data about Maitake D‐Fraction action on breast cancer prevention and its exact molecular mechanisms are not yet elucidated. The experiments were performed employing 25 female BALBc mice that were treated with and without Maitake D‐Fraction Pro4X or Maitake Standard for 15 days by daily intraperitoneal injection. After treatment period, all mice were implanted with murine tumor cells LM3 to induce mammary tumorigenesis. Animals were checked weekly and killed after 46 days of LM3 transplant; percentage of cancer prevention, rate of tumor growing, and overall survival were determined. Under dissection, the internal organs were evaluated histologically and genetically by RT‐PCR. We found that 5 mg/kg per day of Maitake D‐Fraction Pro4X, administered dairy during 15 days to BALBc mice was able to block more than 60% breast cancer development. However, Maitake Standard prevents oncogenesis in 26% to respect control. In this work, we found that Maitake D‐Fraction Pro4X, administered to BALBc mice, prevents breast carcinogenesis, block tumor invasiveness, reduce angiogenesis, and increase overall survival. John Wiley and Sons Inc. 2016-07-11 /pmc/articles/PMC5055164/ /pubmed/27401257 http://dx.doi.org/10.1002/cam4.744 Text en © 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Roldan‐Deamicis, Agustina
Alonso, Eliana
Brie, Belén
Braico, Diego Aguilera
Balogh, Gabriela Andrea
Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice
title Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice
title_full Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice
title_fullStr Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice
title_full_unstemmed Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice
title_short Maitake Pro4X has anti‐cancer activity and prevents oncogenesis in BALBc mice
title_sort maitake pro4x has anti‐cancer activity and prevents oncogenesis in balbc mice
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055164/
https://www.ncbi.nlm.nih.gov/pubmed/27401257
http://dx.doi.org/10.1002/cam4.744
work_keys_str_mv AT roldandeamicisagustina maitakepro4xhasanticanceractivityandpreventsoncogenesisinbalbcmice
AT alonsoeliana maitakepro4xhasanticanceractivityandpreventsoncogenesisinbalbcmice
AT briebelen maitakepro4xhasanticanceractivityandpreventsoncogenesisinbalbcmice
AT braicodiegoaguilera maitakepro4xhasanticanceractivityandpreventsoncogenesisinbalbcmice
AT baloghgabrielaandrea maitakepro4xhasanticanceractivityandpreventsoncogenesisinbalbcmice